BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15161669)

  • 21. Familial chronic lymphocytic leukemia in Israel: A disproportionate distribution among Ashkenazi Jews.
    Zada M; Lerner D; Piltz Y; Perry C; Avivi I; Herishanu Y
    Eur J Haematol; 2017 Jul; 99(1):51-55. PubMed ID: 28370385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival patterns among lymphoma patients with a family history of lymphoma.
    Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
    J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.
    Landgren O; Engels EA; Caporaso NE; Gridley G; Mellemkjaer L; Hemminki K; Linet MS; Goldin LR
    Blood; 2006 Jul; 108(1):292-6. PubMed ID: 16527887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
    Goldin LR; Caporaso NE
    Br J Haematol; 2007 Dec; 139(5):774-9. PubMed ID: 18021091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Established and suggested exposures on CLL/SLL etiology: Results from the CLL-MCC-Spain study.
    Benavente Y; Casabonne D; Costas L; Robles C; Alonso E; de la Banda E; Gonzalez-Barca E; Marcos-Gragera R; Llorca J; Tardón A; Monleon JJ; Aymerich M; Campo E; Gimeno-Vázquez E; Castaño-Vinyals G; Aragonés N; Pollán M; Kogevinas M; de Sanjosé S
    Cancer Epidemiol; 2018 Feb; 52():106-111. PubMed ID: 29289901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
    Zheng G; Chattopadhyay S; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
    Br J Haematol; 2019 Apr; 185(2):232-239. PubMed ID: 30706458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited susceptibility to CLL.
    Speedy HE; Sava G; Houlston RS
    Adv Exp Med Biol; 2013; 792():293-308. PubMed ID: 24014302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial cancer history and chronic lymphocytic leukemia. A case-control study.
    Linet MS; Van Natta ML; Brookmeyer R; Khoury MJ; McCaffrey LD; Humphrey RL; Szklo M
    Am J Epidemiol; 1989 Oct; 130(4):655-64. PubMed ID: 2773914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer.
    Landgren O; Pfeiffer RM; Stewart L; Gridley G; Mellemkjaer L; Hemminki K; Goldin LR; Travis LB
    Int J Cancer; 2007 Mar; 120(5):1099-102. PubMed ID: 17131330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia.
    Ng D; Toure O; Wei MH; Arthur DC; Abbasi F; Fontaine L; Marti GE; Fraumeni JF; Goldin LR; Caporaso N; Toro JR
    Blood; 2007 Feb; 109(3):916-25. PubMed ID: 17047154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia.
    Matos DM; Ismael SJ; Scrideli CA; de Oliveira FM; Rego EM; Falcão RP
    Br J Haematol; 2009 Nov; 147(3):339-46. PubMed ID: 19709083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial chronic lymphocytic leukemia.
    Goldin LR; Slager SL; Caporaso NE
    Curr Opin Hematol; 2010 Jul; 17(4):350-5. PubMed ID: 20389242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.
    Sud A; Chattopadhyay S; Thomsen H; Sundquist K; Sundquist J; Houlston RS; Hemminki K
    Blood; 2019 Sep; 134(12):960-969. PubMed ID: 31395603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order.
    Jønsson V; Tjønnfjord GE; Johannesen TB; Ly B; Olsen JH; Yuille M
    In Vivo; 2010; 24(1):85-95. PubMed ID: 20133982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLL family 'Pedigree 14' revisited: 1947-2004.
    Jønsson V; Houlston RS; Catovsky D; Yuille MR; Hilden J; Olsen JH; Fajber M; Brandt B; Sellick G; Allinson R; Wiik A
    Leukemia; 2005 Jun; 19(6):1025-8. PubMed ID: 15800670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia.
    Bevan S; Catovsky D; Matutes E; Antunovic P; Auger MJ; Ben-Bassat I; Bell A; Berrebi A; Gaminara EJ; Júnior ME; Mauro FR; Quabeck K; Rassam SM; Reid C; Ribeiro I; Stark P; van Dongen JJ; Wimperis J; Wright S; Marossy A; Yuille MR; Houlston RS
    Blood; 2000 Dec; 96(12):3982-4. PubMed ID: 11090088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causation of chronic lymphocytic leukemia--insights from familial disease.
    Houlston RS; Sellick G; Yuille M; Matutes E; Catovsky D
    Leuk Res; 2003 Oct; 27(10):871-6. PubMed ID: 12860003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms.
    Altieri A; Bermejo JL; Hemminki K
    Leukemia; 2005 Dec; 19(12):2342-3. PubMed ID: 16224483
    [No Abstract]   [Full Text] [Related]  

  • 40. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.
    Frisell T; Holmqvist M; Källberg H; Klareskog L; Alfredsson L; Askling J
    Arthritis Rheum; 2013 Nov; 65(11):2773-82. PubMed ID: 23897126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.